← Open Payments lookup

LINDA PROKAI: Open Payments

NPI 1154540847 · CARMEL, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,132 in 53 payments from 10 companies in 2025. Trend: 2023 $2,014 · 2024 $2,166 · 2025 $1,132

Food & beverage: $1,132
CompanyPaymentsAmount
ABBVIE INC.24$431
Neurocrine BioSciences, Inc.6$241
Teva Pharmaceuticals USA, Inc.8$142
Vanda Pharmaceuticals Inc.4$108
Collegium Pharmaceutical, Inc.3$60
PFIZER INC.4$58
Alkermes, Inc.1$33
SI-BONE, INC.1$23
Otsuka America Pharmaceutical, Inc.1$21
E.R. Squibb & Sons, L.L.C.1$15

Products named: INGREZZA, QULIPTA, AUSTEDO XR, VRAYLAR, UBRELVY, HETLIOZ, Belbuca, NURTEC ODT.

Industry payments across IN — which companies pay providers there.